FOLR2 and neoplasm: Sanchez-Paulete et al. use a broad pan-macrophage approach with anti-F4/80 CARs, while Rodriguez-Garcia et al. describe a CAR targeting folate receptor β (FRβ), which is highly expressed on M2-like tumor supporting macrophages.